Overview

Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin

Status:
Completed
Trial end date:
2017-07-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetic Profile and Safety/Tolerability of BCWP_C003 compared to Co-Administration of Crestor 10mg and Glucophage XR 1000mg, and to evaluate the food effect of Pharmacokinetic profile of BCWP_C003 after administration.
Phase:
Phase 1
Details
Lead Sponsor:
BC World Pharm Co. Ltd.
Treatments:
Metformin
Rosuvastatin Calcium